Medicare

OIG: Crack down on Medicare co-pay cards

The Office of the Inspector General says more needs to be done to keep Medicare patients from using the discount cards.

Medicare to cover some hep. C screening

Patients have to be high-risk or Baby Boomers for coverage.

Can we handle cost of a healthy, aging population?

Can we handle cost of a healthy, aging population?

By

The short answer: we're not financially prepared for a slowly aging, healthy population, according to a recently published analysis.

CMS projects healthcare spending to rise

CMS projects healthcare spending to rise

By

Researchers says growth will average 5.8% a year between 2012 and 2022. They also anticipate generics will hit a leveling-off point that will drive average Rx prices upwards

Lilly Alzheimer's tracer fails to win CMS support

Lilly Alzheimer's tracer fails to win CMS support

By

The drug maker asked CMS to approve its Amyvid PET tracer for Medicare beneficiaries, but CMS declined, saying in a draft decision that widespread use would be of little value.

Business briefs: Boehringer Ingelheim, Teva, Medicare

Good and bad news about Pradaxa; Plan B decision not deemed a big threat to Teva's sales; Study says Medicare patients more likely to receive brand-name medications than VA patients

The year ahead: A Capitol bit of crystal ball-gazing

From FDA and pharma, to Caronia and off-label communication, three healthcare policy experts offer their take on what 2013 holds in store.

CBO: more scripts filled, less healthcare spending

By

The nonpartisan Congressional Budget Office is tallying medical savings differently, adding a new perspective to chatter about the financial implications of nonadherence and rising drug prices.

Company news: Nature Publishing Group, Elsevier, Medicare

Nature releases the Antibodypedia's seventh generation, Elsevier adds more board review apps, and how redefining "senior" may not save money in the long run

Voting with their wallets, pharmas say no thanks to change

Voting with their wallets, pharmas say no thanks to change

By

Barack Obama edged Mitt Romney in fundraising from pharmas in the 2012 election, even as the industry favored Republicans in other contests. Were change-weary drug companies voting for the status quo?

Massachusetts overturns co-pay card ban

By

After three years of wrangling, drug companies can again offer co-pay coupons and cards or buy doctors lunch off-site -- with some limitations.

Co-pay cards and coupons sway 2 million US seniors, study says

Co-pay cards and coupons sway 2 million US seniors, study says

By

The National Coalition on Health Care took aim at co-pay cards and coupons with a report suggesting that they might push 2 million US seniors to opt for more expensive branded drugs over generics.

Congress takes a stab at IPAB

By

Congressional Republicans -- and even a few Democrats -- are pressing the attack on the Independent Payment Advisory Board for Medicare, a part of the Affordable Care Act opposed by both PhRMA and the AMA.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.